Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1

The currently available anti-HIV-1 therapeutics is highly beneficial to infected patients. However, clinical failures occur as a result of the ability of HIV-1 to rapidly mutate. One approach to overcome drug resistance is to target HIV-1 proteins that are highly conserved among phylogenetically dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Mattia, Kovalenko, Lesia, Lyonnais, Sébastien, Antaki, Danny, Torbett, Bruce E., Botta, Maurizio, Mirambeau, Gilles, Mély, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122173/
https://www.ncbi.nlm.nih.gov/pubmed/25749978
http://dx.doi.org/10.1007/82_2015_433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122173/
https://www.ncbi.nlm.nih.gov/pubmed/25749978
http://dx.doi.org/10.1007/82_2015_433

Ejemplares similares